Filed before 2025Filed 29 November 2022
Bonum Therapeutics, Inc. raised $45M
Bonum Therapeutics, Inc., a biotech company based in Seattle, WA, raised $45M in a new equity round, according to a filing dated 29 November 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 29 November 2022
- Round
- Equity round
- Amount sold
- $45M
- Offering size
- $93M
- Investors so far
- 10
- Based in
- Seattle, WA
- Website
- bonumtx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 86% of the 1,764 tracked raises with an amount filed in 2022, and than 82% of the 142 in biotech.
Bonum Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Apr 2026 | New filing | $26.9M | Another raise |
| 29 Nov 2022 | New filing | $45M | This raise |
| 22 Dec 2021 | New filing | $1.19M | Another raise |
More with RiverVest on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.